BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.373,23 PKT +13,12 PKT +0,96 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
12.05.20 Nestlé Hold HSBC
11.05.20 Zurich Insurance Outperform Credit Suisse Group
11.05.20 Holcim buy UBS AG
11.05.20 Holcim kaufen Credit Suisse Group
11.05.20 Holcim overweight JP Morgan Chase & Co.
11.05.20 Novartis Neutral UBS AG
08.05.20 Novartis Underweight JP Morgan Chase & Co.
07.05.20 Richemont Neutral Goldman Sachs Group Inc.
07.05.20 ABB (Asea Brown Boveri) buy UBS AG
06.05.20 UBS Hold Deutsche Bank AG
06.05.20 UBS buy Deutsche Bank AG
05.05.20 Swiss Re Hold Deutsche Bank AG
05.05.20 Zurich Insurance Hold Deutsche Bank AG
05.05.20 Nestlé overweight JP Morgan Chase & Co.
05.05.20 Novartis Conviction Buy List Goldman Sachs Group Inc.
04.05.20 Swiss Re Hold Deutsche Bank AG
04.05.20 UBS Equal-Weight Morgan Stanley
04.05.20 UBS Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01.05.20 Swiss Re Hold Deutsche Bank AG
01.05.20 Swiss Re Sector Perform RBC Capital Markets
01.05.20 Swiss Re buy UBS AG
01.05.20 Holcim Outperform Credit Suisse Group
30.04.20 Swiss Re overweight JP Morgan Chase & Co.
30.04.20 Swiss Re Sector Perform RBC Capital Markets
30.04.20 ABB (Asea Brown Boveri) buy UBS AG
30.04.20 Holcim overweight JP Morgan Chase & Co.
30.04.20 ABB (Asea Brown Boveri) buy Kepler Cheuvreux
30.04.20 Holcim buy Goldman Sachs Group Inc.
30.04.20 Swiss Re buy Goldman Sachs Group Inc.
30.04.20 Novartis Hold HSBC
30.04.20 Roche Hold HSBC
29.04.20 UBS Hold Deutsche Bank AG
29.04.20 ABB (Asea Brown Boveri) Underweight Morgan Stanley
29.04.20 Novartis Neutral Credit Suisse Group
29.04.20 UBS Outperform Credit Suisse Group
29.04.20 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
29.04.20 UBS Sector Perform RBC Capital Markets
29.04.20 ABB (Asea Brown Boveri) Hold Deutsche Bank AG
29.04.20 UBS overweight JP Morgan Chase & Co.
29.04.20 Novartis Underweight JP Morgan Chase & Co.